153 related articles for article (PubMed ID: 25719728)
1. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
2. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptomic analysis reveals the landscape of epithelial-mesenchymal transition molecular heterogeneity in esophageal squamous cell carcinoma.
Guo D; Sheng K; Zhang Q; Li P; Sun H; Wang Y; Lyu X; Jia Y; Wang C; Wu J; Zhang X; Wang D; Sun Y; Huang S; Yu J; Zhang J
Cancer Lett; 2024 Apr; 587():216723. PubMed ID: 38342234
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
Guo H; Shu J; Hu G; Liu B; Li J; Sun J; Wang X; Liu H; Xiong S; Tang Y; Yin Y; Wang X
PLoS One; 2024; 19(5):e0302780. PubMed ID: 38713738
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells.
Ma H; Ma X; Qi L; Zhang Q; Wang T; Guo Q; Li P; Zhang S; Liu S
J Gene Med; 2024 Jun; 26(6):e3708. PubMed ID: 38837511
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin is expressed at the invasive front of esophageal squamous cell carcinomas and is involved in collective cell invasion.
Nakashima Y; Yoshinaga K; Kitao H; Ando K; Kimura Y; Saeki H; Oki E; Morita M; Kakeji Y; Hirahashi M; Oda Y; Maehara Y
Cancer Sci; 2013 Dec; 104(12):1718-25. PubMed ID: 24103048
[TBL] [Abstract][Full Text] [Related]
7. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Wang WW; Zhu WG; Yu CH; Tao GZ; Wu QQ; Song YQ; Pan P; Tong YS
Mol Carcinog; 2016 Dec; 55(12):2095-2105. PubMed ID: 26756568
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.
Jiang D; Li X; Wang H; Shi Y; Xu C; Lu S; Huang J; Xu Y; Zeng H; Su J; Hou Y; Tan L
BMC Cancer; 2015 May; 15():377. PubMed ID: 25953424
[TBL] [Abstract][Full Text] [Related]
9. MBIP promotes ESCC metastasis by activating MAPK pathway.
Ma Y; Hua Y; Yin X; Jiao Y; Xu E; Yan T; Yang J; Zhang L
Cell Signal; 2024 Mar; 115():111040. PubMed ID: 38199596
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma.
Kanamoto A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Nov; 49(5):1859-1869. PubMed ID: 27826618
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.
Shi Q; Shen L; Dong B; Fu H; Kang X; Dai L; Yang Y; Yan W; Chen KN
Thorac Cancer; 2018 Jul; 9(7):836-846. PubMed ID: 29757528
[TBL] [Abstract][Full Text] [Related]
12. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
[TBL] [Abstract][Full Text] [Related]
13. CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling.
Zhang X; Xu C; Wang C; Pei Y; He M; Wan Z; Hou J; Wang L
Clin Exp Metastasis; 2024 Apr; 41(2):81-90. PubMed ID: 38396262
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma.
Yang H; Chen Y; Huang X; Gu Y; Chen Z; Mao W
Int J Med Sci; 2024; 21(7):1213-1226. PubMed ID: 38818465
[No Abstract] [Full Text] [Related]
15. Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.
Zhang H; Luo H; Jiang Z; Yue J; Hou Q; Xie R; Wu S
J Radiat Res; 2016 Jul; 57(4):370-80. PubMed ID: 27125498
[TBL] [Abstract][Full Text] [Related]
16. Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma.
Tian J; Lu Z; Niu S; Zhang S; Ying P; Wang L; Zhang M; Cai Y; Dong T; Zhu Y; Zhong R; Wang Z; Chang J; Miao X
Clin Transl Med; 2021 Jun; 11(6):e485. PubMed ID: 34185429
[TBL] [Abstract][Full Text] [Related]
17. JNK2 Promotes Progression of Esophageal Squamous Cell Carcinoma
Wang L; Guo M; Gao L; Liu K; Bai J; Liu Z
Curr Pharm Des; 2023; 29(37):2977-2987. PubMed ID: 37957865
[TBL] [Abstract][Full Text] [Related]
18. IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9.
Shen Z; Zhang P; Zhang W; Luo F; Xu H; Chen S; Kang M
Funct Integr Genomics; 2023 May; 23(2):164. PubMed ID: 37198330
[TBL] [Abstract][Full Text] [Related]
19. JunD-miR494-CUL3 axis promotes radioresistance and metastasis by facilitating EMT and restraining PD-L1 degradation in esophageal squamous cell carcinoma.
Li X; Cong J; Zhou X; Gao W; Li W; Yang Q; Li X; Liu Z; Luo A
Cancer Lett; 2024 Apr; 587():216731. PubMed ID: 38369005
[TBL] [Abstract][Full Text] [Related]
20. Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma.
Liang Y; Hou X; Cui Q; Kang TB; Fu JH; Zhang LJ; Luo RZ; He JH; Zeng YX; Yang HX
J Transl Med; 2012 May; 10():73. PubMed ID: 22533738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
